Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, Steady_T, blanka, 123tom
Search This Board: 
Last Post: 5/25/2019 8:52:02 PM - Followers: 741 - Board type: Free - Posts Today: 114

Anavex Life Sciences Corp (AVXL)

Company website:  http://www.anavex.com/
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052

Anavex®Life Sciences Corp. (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer.  The Company’s lead compound ANAVEX®2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome.

Anavex®Life Sciences’ lead drug candidate, ANAVEX®2-73, recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease.  ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors.  Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. It has also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy and others.  The Michael J. Fox Foundation for Parkinson’s Research has awarded Anavex® a research grant to develop ANAVEX®2-73 for the treatment of Parkinson’s disease to fully fund a preclinical study, which could justify moving ANAVEX®2-73 into a Parkinson’s disease clinical trial.  ANAVEX®3-71, also targeting sigma-1 and M1 muscarinic receptors, is a promising preclinical drug candidate demonstrating disease modifications against the major Alzheimer’s hallmarks in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies, and also with beneficial effects on neuroinflammation and mitochondrial dysfunctions.

The Company is in preparation for ANAVEX®2-73 for a Phase 2/3, placebo-controlled trial in Alzheimer’s disease as well as a Phase 2, placebo-controlled trial in Rett syndrome, for which the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ANAVEX®2-73 and a Phase 2, placebo-controlled trial in Parkinson’s disease.

Headquartered in New York, Anavex® Life Sciences is an American publicly traded corporation on Nasdaq quoted as AVXL

Management:   http://www.anavex.com/about-us/leadership/
Pipeline:  http://www.anavex.com/pipeline/

Patent Info: 

Clinical Trials:  https://clinicaltrials.gov/ct2/results?term=Anavex+Life+Sciences&Search=Search
Recent News:  http://finance.yahoo.com/q?s=avxl&ql=1
Company News Releases:  http://www.anavex.com/2015/?post_type=news
Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=anavex&owner=exclude&action=getcompany
Share Structure:  See SEC filings
Investor Relations:  ir@anavex.com

Marketing Details:  http://convention.bio.org/Printables/Anavex%20Life%20Sciences%20Corp..html


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL News: Quarterly Report (10-q) 05/09/2019 06:12:48 AM
AVXL News: Rett Syndrome Association of Australia and Anavex Life Sciences Announce Initiation of the Phase 2 AVATAR Clinical Study in P... 05/08/2019 08:00:00 AM
AVXL News: Anavex Life Sciences Reports Fiscal 2019 Second Quarter Financial Results and Provides Clinical Study Updates 05/08/2019 07:00:00 AM
AVXL News: Statement of Changes in Beneficial Ownership (4) 05/07/2019 04:33:58 PM
AVXL News: Anavex Life Sciences to Announce Fiscal 2019 Second Quarter Financial Results on Wednesday May 8th, 2019 05/06/2019 07:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#192400  Sticky Note Compiled Due Diligence 05/10/19 XenaLives 05/10/19 02:27:42 PM
#186604  Sticky Note Why would Missling divulge at a conference that Lima4918 03/24/19 01:47:29 PM
#160507  Sticky Note here are a couple of those 32 from cninc 07/30/18 12:01:12 AM
#194344   The farmer has plowed and prepped the fertile tredenwater2 05/25/19 08:52:02 PM
#194343   I'd like to see what Anavex might do mrplmer 05/25/19 08:40:37 PM
#194342   Thanks for pointing that out George. Nidan comment mrplmer 05/25/19 08:38:39 PM
#194341   An interesting lecture that may help people to XenaLives 05/25/19 08:36:40 PM
#194340   If we assume a price for annual treatment georgejjl 05/25/19 07:45:35 PM
#194339   $20 --> $150 --> $12 --> $150 That sage4 05/25/19 07:23:13 PM
#194338   Apparently these people think Anavex may be able XenaLives 05/25/19 07:10:56 PM
#194337   Group Aims to Bring Disease-Associated Biomarker ThroughFDA’s Drug georgejjl 05/25/19 06:45:12 PM
#194336   Anavex 2-73 georgejjl 05/25/19 06:34:48 PM
#194335   Anavex is not a miracle drug. Does it N2deep1 05/25/19 06:29:47 PM
#194334   https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?id=3 nidan7500 05/25/19 06:28:33 PM
#194333   Bull - people in biotech are concerned with XenaLives 05/25/19 06:12:25 PM
#194332   YES!!! Did I note Merck as one of the georgejjl 05/25/19 06:05:42 PM
#194331   PARTNERING PREDICTION: nidan7500 05/25/19 06:02:27 PM
#194330   Its a paycheck just like the folks at N2deep1 05/25/19 05:55:38 PM
#194328   LOL! staff added is in the way of XenaLives 05/25/19 05:53:56 PM
#194326   PARTNERING PREDICTION: georgejjl 05/25/19 05:28:40 PM
#194325   No argument with your daily analysis. Citrati 05/25/19 05:20:40 PM
#194324   And luckily for us Missling is dancing the nidan7500 05/25/19 05:11:17 PM
#194323   Sokol, Thank you for that inspiring reminder. Brilliant thoughts Biostockclub 05/25/19 05:09:45 PM
#194321   Yes. During this Memorial Day weekend, I remember sokol 05/25/19 05:01:42 PM
#194320   RS is in the companies future or blank N2deep1 05/25/19 04:55:06 PM
#194319   Tom. From my experience these early bios generally Citrati 05/25/19 04:53:36 PM
#194317   When are they coming after misleading for participation N2deep1 05/25/19 04:37:23 PM
#194316   I agree it is a good short especially N2deep1 05/25/19 04:34:59 PM
#194315   Chart: great short opportunity any time it gets Sand Piper 05/25/19 04:29:22 PM
#194310   Misleading. There was a Reverse split. N2deep1 05/25/19 03:53:12 PM
#194307   And the basic Fibonacci math targets 123tom 05/25/19 03:49:31 PM
#194303   Another paid pump by Dr Liar. This was kund 05/25/19 02:51:57 PM
#194302   Considering the 150M estimate was pre RS it seems LakeshoreLeo1953 05/25/19 02:25:52 PM
#194301   Interesting, but not credible since See Thru Equity FitzyP33 05/25/19 02:23:26 PM
#194300   This is totally bogus: XenaLives 05/25/19 01:37:31 PM
#194299   https://www.investopedia.com/terms/w/williamsr.asp Investor2014 05/25/19 01:35:20 PM
#194298   The problem with TBI is you don't know XenaLives 05/25/19 01:19:54 PM
#194297   The projection of income for 2020 in this XenaLives 05/25/19 01:18:08 PM
#194296   Surely you must have sued. Did the ohsaycanyousee82 05/25/19 01:12:18 PM
#194295  Restored Pffft >Totally bogus< AVXL is stock way over Sand Piper 05/25/19 01:06:25 PM
#194293   Agreed. Not scary. Citrati 05/25/19 12:53:14 PM
#194291   " about getting a medicine that actually relieves plexrec 05/25/19 12:30:31 PM
#194290   I was under 50 when I suffered bad XenaLives 05/25/19 12:27:02 PM
#194287   It is important to check multiple time frames, XenaLives 05/25/19 12:15:09 PM
#194286   Metrics based on potential market penetration etc also Citrati 05/25/19 11:54:44 AM
#194285   xodcode: Smart of you to get more bennyboy1 05/25/19 11:41:10 AM
#194284   What do you expect from a CEO that N2deep1 05/25/19 11:38:23 AM
#194282  Restored Chart: confirms it !!!! AVXL “Penny stock in the Sand Piper 05/25/19 11:33:44 AM
#194281   Investor2014: Thank you for those kind words. bennyboy1 05/25/19 11:32:50 AM
#194279   The CEO that buys a $3 stock in N2deep1 05/25/19 11:28:18 AM
#194278  Restored It will be longer. The endpoints for the N2deep1 05/25/19 11:26:41 AM
#194277   The almost mid evil practice of waiting for anders2211 05/25/19 11:24:53 AM
#194276   More folk are coming to make it yahoo.. N2deep1 05/25/19 11:24:14 AM